Results for tag: "Turoctocog Alfa"

Turoctocog Alfa is a type of Hematological Drug used to treat hemophilia A, a genetic disorder that impairs the body's ability to form blood clots. It is a recombinant form of Factor VIII, a protein that helps the body form clots. Turoctocog Alfa is used to replace the missing Factor VIII in patients with hemophilia A, allowing them to form clots and prevent bleeding. It is administered intravenously or subcutaneously, depending on the patient's needs. Turoctocog Alfa is a relatively new drug, having been approved by the FDA in 2014. It is used to treat both adults and children with hemophilia A, and is considered to be a safe and effective treatment. The Turoctocog Alfa market is made up of several companies, including Novo Nordisk, Pfizer, and Biogen. These companies produce and distribute the drug, as well as provide support and education to patients and healthcare providers. Additionally, there are several generic versions of the drug available, produced by companies such as Mylan and Sandoz. Show Less Read more